Regional Cancer Care Associates (RCCA) recently attained accreditation from URAC, a leading nonprofit health care benchmark group, as a Specialty Pharmacy in Hackensack, New Jersey.
RCCA’s President and CEO Terrill Jordan called the achievement “a testament to the commitment of delivering the highest level of quality standards to our patients and their caregivers,” while colleagues concurred that the status will enable the organization to continue offering high quality care.
New Jersey-based Regional Cancer Care Associates, ranking among the nation’s largest oncology practitioner networks, strives to bring cancer patients the best treatment possible in a compassionate, community-based structure. RCCA comprises over 100 specialists and 800 staffers at 30 different sites in the New Jersey, Connecticut, Maryland, and Washington, D.C. areas.
“Pharmacy services have never played such an important role in the delivery of care as they do today,” URAC President and CEO Kylanne Green said. “RCCA distinguishes itself for having voluntarily undergone a rigorous review of quality standards that earned it URAC accreditation. Independent URAC accreditation shows RCCA is dedicated to quality and safety, and that it strives for a continual improvement of its services.”
URAC originated as the Utilization Review Accreditation Commission in 1990, abridging its name to the acronym form in 1996 to encompass a wider spectrum of organizations such as health care systems, pharmacies and providers.